Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 271,037 | 151,280 | 176,850 | 156,333 | 157,479 |
| Marketable Securities | 35,298 | 16,741 | 18,477 | 21,864 | 29,043 |
| Receivables | 120,496 | 106,044 | 101,369 | 88,975 | 88,464 |
| Inventories | 109,978 | 104,617 | 103,647 | 103,584 | 103,250 |
| TOTAL | $543,005 | $384,554 | $407,670 | $378,319 | $384,222 |
| Non-Current Assets | |||||
| PPE Net | 280,836 | 278,526 | 243,479 | 238,266 | 232,741 |
| Investments And Advances | 1,998 | 1,462 | 1,758 | 2,414 | 2,690 |
| Other Non-Current Assets | 718,794 | 713,724 | 120,749 | 122,988 | 107,042 |
| TOTAL | $1,001,628 | $993,712 | $365,986 | $363,668 | $342,473 |
| Total Assets | $1,544,633 | $1,378,266 | $773,656 | $741,987 | $726,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 433 | 12,920 | 2,168 | 3,046 | 1,680 |
| Accounts payable and accrued liabilities | 222,719 | 217,536 | 88,886 | 84,242 | 95,796 |
| TOTAL | $257,963 | $251,285 | $105,635 | $94,862 | $102,190 |
| Non-Current Liabilities | |||||
| Long Term Debt | 638,206 | 488,280 | 72,872 | 72,839 | 74,011 |
| Other Non-Current Liabilities | 53,123 | 49,265 | 46,394 | 45,484 | 45,087 |
| TOTAL | $691,530 | $537,746 | $119,444 | $118,467 | $119,340 |
| Total Liabilities | $949,493 | $789,031 | $225,079 | $213,329 | $221,530 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,907 | 48,856 | 48,274 | 47,897 | 48,331 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 373,102 | 323,880 | 297,755 | 271,723 | 237,810 |
| Other shareholders' equity | -8,848 | -8,761 | -7,807 | -8,148 | -10,392 |
| TOTAL | $595,140 | $589,235 | $548,577 | $528,658 | $505,165 |
| Total Liabilities And Equity | $1,544,633 | $1,378,266 | $773,656 | $741,987 | $726,695 |